Altiratinib

Altiratinib(DCC-2701) is a novel c-MET/TIE-2/VEGFR inhibitor; effectively reduce tumor burden in vivo and block c-MET pTyr(1349)-mediated signaling, cell growth and migration as compared with an HGF antagonist in vitro.

Price Not Available 50 mg Altiratinib Supplier Page

Catalog Number	T2054
Alternative Name(s)	DCC-2701
Research Area	Tyrosine Kinase/Adaptors\|\|\|Angiogenesis
Molecular Formula	C26H21F3N4O4
CAS#	1345847-93-9
SMILES	FC1=CC=C(NC(=O)C2(CC2)C(=O)NC2=CC(F)=C(OC3=CC(NC(=O)C4CC4)=NC=C3)C=C2F)C=C1
Size	50 mg
Supplier Page	https://www.targetmol.com/compound/Altiratinib
Additional Information	https://www.targetmol.com/datasheet/T2054